Transgenic microalgae as a non-antibiotic bactericide producer to defend against bacterial pathogen infection in the fish digestive tract.

Antibiotics are commonly employed in most fish aquacultures to prevent disease. One major risk in this practice is that antibiotic-resistant pathogens may be selected. Therefore, we wanted to examine the feasibility of producing an economical, non-antibiotic alternative. The microalga Nannochloropsis oculata is an essential phytoplankton used as live feed for fish larvae. We attempted to culture N. oculata in a way that would provide an organism against bacterial pathogenic infection. To test this idea, we constructed an algae-codon-optimized bovine lactoferricin (LFB) fused with a red fluorescent protein (DsRed) driven by a heat-inducible promoter, which is a heat shock protein 70A promoter combined with a ribulose-1,5-bisphosphate carboxylase/oxygenase small subunit 2' promoter from Chlamydomonas reinhardtii. After electroporation, we examined 491 microalgal clones and generated two stable transgenic lines, each expressing a stable transgene inheritance for at least 26 months. This was confirmed by the positive detection of the mRNA transcript and the protein of LFB-DsRed produced by the transgenic microalgae. To test the efficacy of the antimicrobial peptide LFB, medaka fish (Oryzias latipes) were adapted from freshwater to seawater and were fed with the transgenic algae by oral-in-tube delivery method. Bacterial infection with 1 x 10(5)Vibrio parahaemolyticus per fish was induced 6h thereafter by oral-in-tube delivery as well. For medaka fish fed with 1 x 10(8) transgenic algae per fish, the average survival rate after a 24-h period of infection was much higher than that of medaka fed with wild-type algae (85+/-7.1% versus 5+/-7.1%). This result suggests that medaka fish fed with the LFB-containing transgenic microalgae will have bactericidal defense against V. parahaemolyticus infection in its digestive tract.

[1]  K. Yamauchi,et al.  Antibacterial activity of lactoferrin and a pepsin-derived lactoferrin peptide fragment , 1993, Infection and immunity.

[2]  R. Guillard,et al.  Culture of Phytoplankton for Feeding Marine Invertebrates , 1975 .

[3]  A. Sukenik,et al.  Potential advantages of frozen algae (Nannochloropsis sp.) for rotifer (Brachionus plicatilis) culture , 1995 .

[4]  Guanpin Yang,et al.  Fusion expression of bovine lactoferricin in Escherichia coli. , 2006, Protein expression and purification.

[5]  T. Yip,et al.  Direct evidence of the generation in human stomach of an antimicrobial peptide domain (lactoferricin) from ingested lactoferrin. , 1998, Biochimica et biophysica acta.

[6]  Ju-Hoon Lee,et al.  Expression of the cationic antimicrobial peptide lactoferricin fused with the anionic peptide in Escherichia coli , 2006, Applied Microbiology and Biotechnology.

[7]  Hugo Naya,et al.  Translational selection shapes codon usage in the GC‐rich genome of Chlamydomonas reinhardtii , 2001, FEBS letters.

[8]  Mario R Tredici,et al.  Growth medium recycling in Nannochloropsis sp. mass cultivation. , 2003, Biomolecular engineering.

[9]  Håvard Jenssen,et al.  Lactoferrin and lactoferricin inhibit Herpes simplex 1 and 2 infection and exhibit synergy when combined with acyclovir. , 2003, Antiviral research.

[10]  M. Tomita,et al.  Antibacterial spectrum of lactoferricin B, a potent bactericidal peptide derived from the N-terminal region of bovine lactoferrin. , 1992, The Journal of applied bacteriology.

[11]  R. Burlingame,et al.  Stable Transformation of Chlorella: Rescue of Nitrate Reductase-Deficient Mutants with the Nitrate Reductase Gene , 1997, Current Microbiology.

[12]  S. Deo,et al.  Metal Affinity-Based Purification of a Red Fluorescent Protein , 2007 .

[13]  K. Yamauchi,et al.  Identification of the bactericidal domain of lactoferrin. , 1992, Biochimica et biophysica acta.

[14]  K. Yamauchi,et al.  Toxoplasma gondii: parasiticidal effects of bovine lactoferricin against parasites. , 1995, Experimental parasitology.

[15]  Christoph Griesbeck,et al.  Chlamydomonas reinhardtii , 2006, Molecular biotechnology.

[16]  R. Proctor,et al.  Staphylococcus aureus small colony variants are resistant to the antimicrobial peptide lactoferricin B. , 2005, The Journal of antimicrobial chemotherapy.

[17]  K. Kindle.  High-frequency nuclear transformation of Chlamydomonas reinhardtii. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[18]  J. Gwo,et al.  Cryopreservation of a marine microalga, Nannochloropsis oculata (Eustigmatophyceae). , 2005, Cryobiology.

[19]  W. Smith,et al.  Culture of Marine Invertebrate Animals , 1975, Springer US.

[20]  Richard L. Hawkins,et al.  Expression of Human Growth Hormone by the Eukaryotic Alga, Chlorella , 1999, Current Microbiology.

[21]  Z. Cohen,et al.  Chemicals from Microalgae , 1999 .

[22]  Richard A Lerner,et al.  Expression and assembly of a fully active antibody in algae , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[23]  F. Lu,et al.  Heterologous expression of bovine lactoferricin in Pichia methanolica , 2007, Biochemistry (Moscow).

[24]  J. Rochaix,et al.  The argininosuccinate lyase gene of Chlamydomonas reinhardtii: an important tool for nuclear transformation and for correlating the genetic and molecular maps of the ARG7 locus. , 1989, The EMBO journal.

[25]  H. Tsai,et al.  Molecular cloning and expression of yellowfin porgy (Acanthopagrus latus houttuyn) growth hormone cDNA. , 1993, Comparative biochemistry and physiology. B, Comparative biochemistry.

[26]  F. Gillin,et al.  Copyright � 1995, American Society for Microbiology Giardicidal Activity of Lactoferrin and N-Terminal Peptides , 1995 .

[27]  S. Mayfield,et al.  Development of a GFP reporter gene for Chlamydomonas reinhardtii chloroplast. , 2002, The Plant journal : for cell and molecular biology.

[28]  A. Grossman,et al.  Transformation of the diatom Phaeodactylum tricornutum (Bacillariophyceae) with a variety of selectable marker and reporter genes , 2000 .

[29]  Wenbin Li,et al.  Highly efficient expression of rabbit neutrophil peptide-1 gene in Chlorella ellipsoidea cells , 2001, Current Genetics.

[30]  A. Pietrantoni,et al.  Heparin‐interacting sites of bovine lactoferrin are involved in anti‐adenovirus activity , 2003, Journal of medical virology.

[31]  Mitsunori Takase,et al.  Killing of Candida albicans by lactoferricin B, a potent antimicrobial peptide derived from the N-terminal region of bovine lactoferrin , 1993, Medical Microbiology and Immunology.

[32]  K. Yamauchi,et al.  Bovine lactoferrin and lactoferricin derived from milk: production and applications. , 2002, Biochemistry and cell biology = Biochimie et biologie cellulaire.

[33]  K. Yamauchi,et al.  Reduction of the infectivity of Toxoplasma gondii and Eimeria stiedai sporozoites by treatment with bovine lactoferricin. , 2001, The Journal of veterinary medical science.

[34]  J. Poncet,et al.  Cryopreservation of the unicellular marine alga, Nannochloropsis oculata , 2003, Biotechnology Letters.

[35]  Huiyun Chang,et al.  Foot-and-mouth disease virus VP1 protein fused with cholera toxin B subunit expressed in Chlamydomonas reinhardtii chloroplast , 2003, Biotechnology Letters.

[36]  T. Atkins.  Biodegradation of poly(ethylene adipate) microcapsules in physiological media. , 1998, Biomaterials.

[37]  M. Schroda,et al.  The HSP70A promoter as a tool for the improved expression of transgenes in Chlamydomonas. , 2000, The Plant journal : for cell and molecular biology.

[38]  M. Coventry,et al.  The effect of bovine lactoferrin and lactoferricin B on the ability of feline calicivirus (a norovirus surrogate) and poliovirus to infect cell cultures , 2003, Journal of applied microbiology.

[39]  K. Yoshida,et al.  Expression of a foreign gene in Chlamydomonas reinhardtii chloroplast. , 1999, Journal of bioscience and bioengineering.